FindTrial
Sign In

Expression of cancer cell markers in cervical cancer

Expression of ALDH1A1 and NANOG in squamous cell carcinoma of cervix - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/071663
Enrollment
60
Registered
2024-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cases diagnosed with squamous cell carcinoma of cervix.

Exclusion criteria

Exclusion criteria: Patient who have already received chemotherapy and radiotherapy for squamous cell carcinoma cervix.

Design outcomes

Primary

MeasureTime frame
Prevalence of expression of ALDH1A1 and NANOG in squamous cell carcinoma of cervixTimepoint: Baseline—

Secondary

MeasureTime frame
The association of ALDH1a1 and NANOG with clinicopathological parameters of squamous cell carcinoma cervix.Timepoint: Baseline—

Countries

India

Contacts

Public ContactDr Shramana Mandal

Maulana Azad Medical College

shra_mana@hotmail.com9811686401

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026